echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The most complete list of cancer-targeted and immunotherapy drugs in history (including health insurance coverage and prices)!

    The most complete list of cancer-targeted and immunotherapy drugs in history (including health insurance coverage and prices)!

    • Last Update: 2021-01-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Do you want to fully understand the current domestic and foreign targeted immunotherapy drugs for different types of cancer? Which drugs are available domestically and covered by health insurance? Today, the small editor specially took out a collection of accumulated treasures to share with you, that is, according to the classification of cancer categories covering more than 20 cancer-specific immune drugs, involving these drugs listed at home and abroad, NCCN and CSCO guidelines recommended super-drug instructions and medical insurance inclusion and other cases (see table below), in this shared to fight in the front line of the cancer medical workers, patients and their families, with a view to promoting the domestic cancer precision treatment process, with a view to promoting more cancer patients.
    Immune checkpoint inhibitor lung cancer breast cancer colorectal cancer stomach cancer gastrointestinal mesothelioma bile tube cancer esophageal cancer pancreatic cancer primary peritoneal cancer neuroendocrine cancer prostate cancer bladder cancer kidney cancer cervical cancer fallopian tube cancer ovarian cancer leukemia lymphoma multiple myeloma Merkel cell carcinoma base cell carcinoma head and neck tumor soft tissue carelli Squamous non-small cell lung cancer adaptation, hepatocellular carcinoma second-line adaptation, esophageal squamous cancer second-line adaptation;
    the following drugs are also covered by health insurance: soraphine and gregorinib liver cancer; time and drug names are updated as follows: Pfizer's Dacomitinib is on the market in May 2019, Chinese translation is Dacotinib December 2019 The State Drug Administration announced that the two-targeted joint therapeutic drugs applicable to the treatment of BRAF V600 mutation-positive non-excisible or metastasis melanoma, Novartic Tumor's Darafini (commodity name Tefil) and Qumetini (commodity name Maginen) dual-targeted combined therapy drug have been licensed in China.
    to target the new drug Hessele (generic name: Enmetro-Zhu single resistance) on the market! This is the first antibody conjugate drug approved in China (english name Antibody-drug Conjugate, abbreviated as ADC).
    in February 2020 Roche's PDL1 monoantimmune in February 2020, with symptoms of small cell lung cancer and hepatocellular carcinoma.
    Avelumab is from Merck, Germany, not Merca East.
    carelli's single anti-phobias: lung, esophageal and liver cancers.
    apatini to increase stomach cancer adaptation.
    above, AstraZenecom's "Devaru single resistance" China has been listed, the name corrected to "Dvaliyu single resistance."
    source: Global Network of Oncologists
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.